CDXC logo

Niagen Bioscience, Inc. (CDXC) Net Income

Annual Net Income:

$8.55M+$13.49M(+273.15%)
December 31, 2024

Summary

  • As of today, CDXC annual net profit is $8.55 million, with the most recent change of +$13.49 million (+273.15%) on December 31, 2024.
  • During the last 3 years, CDXC annual net income has risen by +$35.68 million (+131.52%).

Performance

CDXC Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCDXCincome statement metrics

Quarterly Net Income:

$5.06M-$2.12M(-29.47%)
March 31, 2025

Summary

  • As of today, CDXC quarterly net profit is $5.06 million, with the most recent change of -$2.12 million (-29.47%) on March 31, 2025.
  • Over the past year, CDXC quarterly net income has increased by +$5.55 million (+1129.07%).

Performance

CDXC Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCDXCincome statement metrics

TTM Net Income:

$14.11M+$5.55M(+64.97%)
March 31, 2025

Summary

  • As of today, CDXC TTM net profit is $14.11 million, with the most recent change of +$5.55 million (+64.97%) on March 31, 2025.
  • Over the past year, CDXC TTM net income has increased by +$17.63 million (+499.80%).

Performance

CDXC TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherCDXCincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CDXC Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+273.1%+1129.1%+499.8%
3Y3 Years+131.5%+165.4%+151.3%
5Y5 Years+126.6%+185.8%+162.2%

CDXC Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+131.5%-29.5%+331.1%at high+169.0%
5Y5-Yearat high+126.6%-29.5%+157.2%at high+149.8%
All-TimeAll-Timeat high+125.7%-29.5%+157.2%at high+141.6%

CDXC Net Income History

DateAnnualQuarterlyTTM
Mar 2025
-
$5.06M(-29.5%)
$14.11M(+65.0%)
Dec 2024
$8.55M(+273.1%)
$7.18M(+282.3%)
$8.55M(+475.8%)
Sep 2024
-
$1.88M(>+9900.0%)
$1.49M(+209.8%)
Jun 2024
-
-$15.00K(+97.0%)
-$1.35M(+61.7%)
Mar 2024
-
-$492.00K(-531.6%)
-$3.53M(+28.6%)
Dec 2023
-$4.94M(+70.1%)
$114.00K(+111.9%)
-$4.94M(+23.7%)
Sep 2023
-
-$959.00K(+56.2%)
-$6.47M(+0.4%)
Jun 2023
-
-$2.19M(-15.2%)
-$6.50M(+39.3%)
Mar 2023
-
-$1.90M(-34.1%)
-$10.70M(+35.3%)
Dec 2022
-$16.54M(+39.0%)
-$1.42M(-44.0%)
-$16.54M(+19.1%)
Sep 2022
-
-$985.00K(+84.6%)
-$20.45M(+27.8%)
Jun 2022
-
-$6.40M(+17.4%)
-$28.32M(-3.0%)
Mar 2022
-
-$7.74M(-45.4%)
-$27.49M(-1.3%)
Dec 2021
-$27.13M(-36.2%)
-$5.33M(+39.9%)
-$27.13M(+2.8%)
Sep 2021
-
-$8.86M(-59.1%)
-$27.90M(-20.0%)
Jun 2021
-
-$5.57M(+24.6%)
-$23.26M(-8.7%)
Mar 2021
-
-$7.38M(-21.1%)
-$21.40M(-7.4%)
Dec 2020
-$19.93M(+38.0%)
-$6.10M(-44.7%)
-$19.93M(+12.2%)
Sep 2020
-
-$4.21M(-13.6%)
-$22.68M(+11.6%)
Jun 2020
-
-$3.71M(+37.1%)
-$25.67M(+13.6%)
Mar 2020
-
-$5.90M(+33.3%)
-$29.71M(+7.6%)
Dec 2019
-$32.15M(+3.5%)
-$8.85M(-22.9%)
-$32.15M(-2.0%)
Sep 2019
-
-$7.20M(+7.1%)
-$31.51M(+4.3%)
Jun 2019
-
-$7.75M(+7.0%)
-$32.91M(+0.9%)
Mar 2019
-
-$8.34M(-1.4%)
-$33.21M(+0.3%)
Dec 2018
-$33.32M(-192.8%)
-$8.22M(+4.5%)
-$33.32M(+1.8%)
Sep 2018
-
-$8.61M(-6.9%)
-$33.92M(-46.3%)
Jun 2018
-
-$8.05M(+4.7%)
-$23.18M(-29.5%)
Mar 2018
-
-$8.44M(+4.3%)
-$17.89M(-57.3%)
Dec 2017
-$11.38M(-288.6%)
-$8.82M(-512.8%)
-$11.38M(-141.9%)
Sep 2017
-
$2.14M(+177.3%)
-$4.70M(+39.7%)
Jun 2017
-
-$2.76M(-43.3%)
-$7.79M(-52.4%)
Mar 2017
-
-$1.93M(+10.1%)
-$5.11M(-74.6%)
Dec 2016
-$2.93M
-$2.15M(-124.9%)
-$2.93M(-32.6%)
Sep 2016
-
-$954.40K(-1054.1%)
-$2.21M(-75.6%)
Jun 2016
-
-$82.70K(-132.4%)
-$1.26M(+15.6%)
DateAnnualQuarterlyTTM
Mar 2016
-
$255.60K(+117.9%)
-$1.49M(+46.2%)
Dec 2015
-$2.77M(+48.6%)
-$1.43M(>-9900.0%)
-$2.77M(-7.7%)
Sep 2015
-
-$3700.00(+98.8%)
-$2.57M(+20.3%)
Jun 2015
-
-$315.20K(+69.3%)
-$3.23M(+29.3%)
Mar 2015
-
-$1.03M(+16.4%)
-$4.57M(+15.3%)
Dec 2014
-$5.39M(-21.9%)
-$1.23M(-86.1%)
-$5.39M(-10.3%)
Sep 2014
-
-$659.70K(+60.1%)
-$4.89M(+10.8%)
Jun 2014
-
-$1.65M(+10.5%)
-$5.48M(-13.1%)
Mar 2014
-
-$1.85M(-155.1%)
-$4.84M(-9.6%)
Dec 2013
-$4.42M(+62.1%)
-$724.30K(+42.1%)
-$4.42M(+18.1%)
Sep 2013
-
-$1.25M(-22.5%)
-$5.39M(+5.1%)
Jun 2013
-
-$1.02M(+28.3%)
-$5.68M(+34.4%)
Mar 2013
-
-$1.42M(+16.2%)
-$8.65M(+25.8%)
Dec 2012
-$11.66M(-47.7%)
-$1.70M(-10.4%)
-$11.66M(+6.4%)
Sep 2012
-
-$1.54M(+61.5%)
-$12.46M(+6.5%)
Jun 2012
-
-$3.99M(+9.9%)
-$13.32M(-19.3%)
Mar 2012
-
-$4.43M(-77.9%)
-$11.17M(-41.5%)
Dec 2011
-$7.89M(-284.8%)
-$2.49M(-3.6%)
-$7.89M(-25.3%)
Sep 2011
-
-$2.40M(-30.5%)
-$6.30M(-31.8%)
Jun 2011
-
-$1.84M(-59.3%)
-$4.78M(-47.5%)
Mar 2011
-
-$1.16M(-28.7%)
-$3.24M(-58.0%)
Dec 2010
-$2.05M(-126.1%)
-$898.70K(-1.8%)
-$2.05M(-61.8%)
Sep 2010
-
-$883.20K(-191.0%)
-$1.27M(-125.5%)
Jun 2010
-
-$303.50K(-1000.6%)
-$562.40K(-2.3%)
Mar 2010
-
$33.70K(+129.3%)
-$550.00K(+39.4%)
Dec 2009
-$907.60K(+56.9%)
-$115.10K(+35.2%)
-$907.50K(+37.1%)
Sep 2009
-
-$177.50K(+39.0%)
-$1.44M(+27.0%)
Jun 2009
-
-$291.10K(+10.1%)
-$1.97M(+14.3%)
Mar 2009
-
-$323.80K(+50.1%)
-$2.31M(-16.2%)
Dec 2008
-$2.10M(-5380.5%)
-$649.50K(+8.6%)
-$1.98M(-48.7%)
Sep 2008
-
-$710.30K(-14.3%)
-$1.33M(-111.1%)
Jun 2008
-
-$621.70K(>-9900.0%)
-$632.40K(-4550.0%)
Feb 2008
-
-$2900.00(+17.1%)
-$13.60K(+41.6%)
Nov 2007
-$38.40K
-$3500.00(+18.6%)
-$23.30K(-17.7%)
Aug 2007
-
-$4300.00(-48.3%)
-$19.80K(-27.7%)
May 2007
-
-$2900.00(+77.0%)
-$15.50K(-23.0%)
Feb 2007
-
-$12.60K
-$12.60K

FAQ

  • What is Niagen Bioscience, Inc. annual net profit?
  • What is the all-time high annual net income for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. annual net income year-on-year change?
  • What is Niagen Bioscience, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. quarterly net income year-on-year change?
  • What is Niagen Bioscience, Inc. TTM net profit?
  • What is the all-time high TTM net income for Niagen Bioscience, Inc.?
  • What is Niagen Bioscience, Inc. TTM net income year-on-year change?

What is Niagen Bioscience, Inc. annual net profit?

The current annual net income of CDXC is $8.55M

What is the all-time high annual net income for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high annual net profit is $8.55M

What is Niagen Bioscience, Inc. annual net income year-on-year change?

Over the past year, CDXC annual net profit has changed by +$13.49M (+273.15%)

What is Niagen Bioscience, Inc. quarterly net profit?

The current quarterly net income of CDXC is $5.06M

What is the all-time high quarterly net income for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high quarterly net profit is $7.18M

What is Niagen Bioscience, Inc. quarterly net income year-on-year change?

Over the past year, CDXC quarterly net profit has changed by +$5.55M (+1129.07%)

What is Niagen Bioscience, Inc. TTM net profit?

The current TTM net income of CDXC is $14.11M

What is the all-time high TTM net income for Niagen Bioscience, Inc.?

Niagen Bioscience, Inc. all-time high TTM net profit is $14.11M

What is Niagen Bioscience, Inc. TTM net income year-on-year change?

Over the past year, CDXC TTM net profit has changed by +$17.63M (+499.80%)
On this page